G. John Mohr
G. John Mohr is a Managing Partner and co-founder of BioAsset Advisors. John is a multidimensional drug industry consultant and former executive with expertise in managing emerging company issues. His distinguished career includes management of multi-million dollar brands and building products from ‘bench-to-market’.
Prior to founding BioAsset Advisors, he led Business and Corporate Development at CV Therapeutics leading to a major licensing deal and subsequent $1.4 billion M&A transaction with Gilead. John possesses a portfolio of worldwide contacts and provides significant experience in closing successful licensing and M&A transactions. His experience includes President of Fournier Pharma where he was responsible for operations including clinical development, regulatory and business development activities.
He built a strategic partnership with Abbott for TriCor®/ Trilipix, a $1.5 billion cardiovascular brand. While at Merck, he lead Financial Services for North America operations followed by six years of responsibility for Marketing and New Product Planning, including worldwide marketing franchise head for the blockbuster brand Pepcid®.
John is a CPA and a graduate of Drexel University with a BS in Finance & Accounting.